Company News in the Life Science Industry

»

Reset 

Marrone Bio Seed Treatments Demonstrate Improved Yields and Cost-Effective Control

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Marrone Bio Innovations, Inc.

Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Syneos Health, Inc

Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Abeona Therapeutics, Inc.

Shineco, Inc. Announces Progress with CBD Product System Construction

Read more ››
By: GlobenewsWire - 09 Dec 2019

Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clini

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Onconova Therapeutics, Inc.

Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol “KLFE”

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Kannalife, Inc.

Flexion Therapeutics to Host Physician Event at Orthopaedic Summit 2019 Featuring Panel of Former Professional Athletes Treated With ZILRETTA® for Osteoarthritis Knee Pain

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Flexion Therapeutics Inc.

Colombia’s FEDECORE and One World Pharma Join Forces to Develop Large Scale Hemp Projects Benefiting Small Farmers

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  ONE WORLD DMG / PHARMADESIGN INC.

Virbac : Declaration of the number of shares and voting rights 11/2019

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Virbac

Ocugen Announces Completion of 50% of Enrollment of its Phase 3 Clinical Trial for ocular GVHD

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Ocugen, Inc.

Aino Health AB (publ): Outcome of the exercise of warrants in Aino Health AB (publ) 9.12.2019

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Aino Health AB (publ)

Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Constellation Pharmaceuticals, Inc.

Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Molecular Templates, Inc.

Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Achillion Pharmaceuticals, Inc.

Researchers Present Preclinical Data Showing Synergistic Activity of SpringWorks Therapeutics’ Gamma Secretase Inhibitor (Nirogacestat) with GlaxoSmithKline’s BCMA Antibody-Drug Conjugate (Belantamab Mafodotin) at the American Society of Hematology (

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  SpringWorks Therapeutics Inc.

Atara Biotherapeutics Reports Updated Long-Term Clinical Results from a Tab-cel® Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st Amer

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Atara Biotherapeutics, Inc.

Agios Presents Updated Data for Mitapivat from Extension Phase of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Agios Pharmaceuticals, Inc.

Forty Seven, Inc. Announces Foundational Preclinical Data Supporting the Development of FSI-174 in Combination with Magrolimab as a Novel All Antibody Conditioning Regimen for Hematopoietic Stem Cell Transplantation

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Forty Seven Inc.

ORYZON Presents New Efficacy Data From its Phase II Trial ALICE Investigating iadademstat in AML

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Oryzon Genomics, S.A.

Generex Biotechnology Provides Update on Pending Dividend

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 50,000 companies